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Fatigue reduces productivity and is a risk factor for lifestyle diseases and mental disorders. Everyone
experiences physiological fatigue and recovers with rest. Pathological fatigue, however, greatly reduces
quality of life and requires therapeutic interventions. It is therefore necessary to distinguish between the
two but there has been no biomarker for this. We report on the measurement of salivary human
herpesvirus (HHV-) 6 and HHV-7 as biomarkers for quantifying physiological fatigue. They increased
with military training and work and rapidly decreased with rest. Our results suggested that macrophage
activation and differentiation were necessary for virus reactivation. However, HHV-6 and HHV-7 did not
increase in obstructive sleep apnea syndrome (OSAS), chronic fatigue syndrome (CFS) and major
depressive disorder (MDD), which are thought to cause pathological fatigue. Thus, HHV-6 and HHV-7
would be useful biomarkers for distinguishing between physiological and pathological fatigue. Our
ﬁndings suggest a fundamentally new approach to evaluating fatigue and preventing fatigue-related
diseases.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Resulting fromwork-related or other stress or insomnia, fatigue
is something that everyone experiences. Long-term fatigue can
cause cardiovascular dysfunction, mental disorders such as
depression, and occupational sudden death (karoshi) [1e3]. Fatigue
is therefore a major social problem.
People recover from physiological fatigue with rest. Pathological
fatigue, however, persists for 3 months or more and greatly affects
QOL [4]. As the latter requires therapeutic interventions, we mustInc. This is an open access article udistinguish between physiological and pathological fatigue. In this
study, we investigated potential biomarkers for objectively
assessing fatigue.
Fatigue is frequently assessed by self-reporting using the
Checklist Individual Strength, Proﬁle of Mood States or visual
analog scales [5,6]. However, its perception is inﬂuenced by nega-
tive or positive work events and compensation practices can
motivate workers to distort self-reported fatigue levels [7], which
therefore may not be a correct indicator.
We focused on human herpesvirus (HHV-) 6 and HHV-7, which
are reactivated by fatigue. These viruses cause exanthem subitum
and establish latency in almost all individuals [8]. Frequently
reactivated and shed in saliva, they are potentially a useful fatigue
biomarker [9]. HHV-6 is reportedly useful for monitoring cognitivender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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HHV-7 for assessing fatigue in end-stage renal disease [12].
We assessed fatigue prior to, during and after Japan Self-Defense
Force (JSDF) military training using HHV-6 and HHV-7 DNA quan-
tities. The JSDF was considered to be a uniform population
regarding sleep, diet and other characteristics, with few con-
founding factors. We also investigated the mechanism of HHV-6
and HHV-7 reactivation in a mouse fatigue model, focusing on
changes in inﬂammatory cytokines and CD14 and CD16 expressions
in spleens due to fatigue. Research has shown that HHV-6 latently
infects monocytes/macrophages [13] and that inﬂammatory cyto-
kines play an important role in its reactivation [14]. Inﬂammatory
cytokines are reportedly involved in monocyte activation and dif-
ferentiation [15] and mature macrophages are positive for CD14
and CD16 [16,17], markers of their differentiation.
We also measured salivary HHV-6 and HHV-7 DNA quantities in
patients with obstructive sleep apnea syndrome (OSAS), chronic
fatigue syndrome (CFS) and major depressive disorder (MDD),
which are thought to cause pathological fatigue, and normal con-
trols (NCs). In OSAS, repeated episodes of upper-airway obstruction
during sleep and cause nocturnal awakening, impairment of sound
sleep, and other forms of insomnia. Causing daytime sleepiness and
fatigue [18,19], OSAS is a major societal problem because sufferers
become less efﬁcient at work. CFS is triggered by complex condi-
tions, including infection, and its diagnosis requires 6 months of
unexplained fatigue that is not alleviated by rest, with 4 of 8
additional symptoms (e.g. unrefreshing sleep, sore throat, muscle
pain) [20]. Depression is a lowmental statewith loss of interest and
feeling of joy, that is frequently accompanied by fatigue [21].
To determine the usefulness of salivary HHV-6 and HHV-7 as
fatigue biomarkers, we used subjects with physiological fatigue and
those with pathological fatigue.
2. Materials and methods
2.1. Ethics statement
The study was approved by the Ethics Committees of the Jikei
University School of Medicine, National Defense Medical College,
Osaka City University, Soiken Inc. and Soiken Clinic. Written
informed consent was obtained from each subject. Animal experi-
ments were approved by the Institutional Animal Care and Use
Committee of the Jikei University.
2.2. Participants
Members of the Japan Self Defense Force (JSDF) 1st Airborne
Brigade participating in 9-week ranger training were recruited for
the study [22]. It was conﬁrmed that participants had no serious
physical diseases or previous psychiatric illnesses from the results
of annual physical examinations and pre-training selection exam-
inations. Those who dropped out during the training were
excluded. All were male and their average age was 26.6 ± 0.4
[mean ± s.e.m.] years (n ¼ 55). The training program basically
consisted of self-training for a week, a day’s rest, base training for 4
weeks, a day’s rest and then 4 week’s of ﬁeld training. Subjects
rated their fatigue level on a visual analog scale (VAS) whose total
score ranged from 0 (no fatigue) to 100 (total exhaustion) at four
time points: before training (2 days before training), during base-
training (2 weeks into training), during ﬁeld-training (3 weeks
into training), and after training (3e5 days after end of the training)
[22]. Saliva samples were all collected at the same time.
We also recruited 113 NCs (49 females, 64 males; age 43.5 ± 0.8
[mean ± s.e.m.]) using an advertisement. Exclusion criteria were
history of medical illness, taking chronic medication orsupplemental vitamins, body weight less than 40 kg, and blood
donation within one month before the study or blood hemoglobin
level less than 12.0 g/dl.
Regarding pathological fatigue, 42 patients aged 20e64 years
who were diagnosed with OSAS at Jikei University Hospital (Tokyo)
(6 females, 36 males; age 49.8 ± 1.7 [mean ± s.e.m.]) were enrolled.
Diagnosis was by overnight polysomnography (PSG) in accordance
with the International Classiﬁcation of Sleep Disorders (ICSD-2)
[23]. Also enrolled were 97 CFS patients (68 females, 29 males; age
37.8 ± 0.8 [mean ± s.e.m.]) aged between 20 and 64 years whowere
diagnosed at the Osaka City University Hospital based on the 1994
revised working case deﬁnition of Centers for Disease Control and
Prevention (CDC) [20]. Symptoms were assessed using the Chalder
Fatigue Scale [24]. We additionally enrolled 33 MDD patients (10
females, 23 males; age 45.3 ± 1.9 [mean ± s.e.m.]) aged between 20
and 64 years whowere diagnosed at the Jikei University Hospital or
the Jikei University Kashiwa Hospital based on the Diagnostic and
Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) [21].
Depressive symptoms were assessed using the Montgomery-
Asberg depression rating scale (MADRS) [25,26].
Saliva samples of less than 200 mL were omitted from the
analysis.2.3. Measurement of salivary HHV-6, HHV-7
Saliva samples were collected in a test tube (Salivette; Sarstedt
AG& Co.). Following centrifugation, the ﬂow-throughwas stored at
80 C until analyzed. Viral DNAwas extracted from 400 ml saliva or
phosphate-buffered saline-diluted samples by automatic isolation
with the BioRobot EZ1 workstation and EZ1 virus mini kit v2.0
(QIAGEN, Inc.), according to the manufacturer’s protocol. DNA was
eluted in 90 ml of elution buffer. Copies of HHV-6 and HHV-7 DNA in
the saliva samples were quantiﬁed by real-time PCR with an
Applied Biosystems 7300 real-time PCR System (Applied Bio-
systems). Ampliﬁcations were performed in duplicate in a total
volume of 50 ml containing 25 ml of Premix Ex Taq (Perfect Real
Time) (Takara Bio Inc.), 0.45 ml of PCR forward primer (100 mM),
0.45 ml of PCR reverse primer (100 mM), 1.25 ml of TaqMan probe
(10 mM),1 ml of Rox reference dye, 5 ml of the viral DNA, and 16.85 ml
of PCR-grade water. The primers used for real-time PCR were as
follows: HHV-6 forward primer, 50-GACAATCACATGCCTGGA-
TAATG-30; HHV-6 reverse primer, 50-TGTAAGCGTGTGGTAATGGAC-
TAA-30; HHV-6 probe, 50-FAM-AGCAGCTGGCGAAAAGTGCTGTGC-
TAMRA-30; HHV-7 forward primer, 50-CGGAAGTCACTGGAGTAAT-
GAC-30; HHV-7 reverse primer, 50-CCAATCCTTCCGAAACCGAT-30;
and HHV-7 probe, 50-FAM-CCTCGCAGATTGCTTGTTGGCCATG-
TAMRA-30 [27,28]. The thermal proﬁle was 95 C for 30 s, followed
by 50 cycles of 95 C for 5 s and 60 C for 31 s. Data analysis used
Sequence Detection Software version 1.4 (Applied Biosystems).2.4. Animals
Six-week-old C57BL/6NCrSlc male mice were purchased from
SLC Japan. They were housed in standard cages in a temperature-
and humidity-controlled room with a 12-h light/dark cycle (lights
on at 8:00) and free access to standard lab chow and water. We
modiﬁed a rat model of fatigue for application to mice [29]. Brieﬂy,
the mice were divided into two groups: control group (Control)
with no stress load and 24-h group (Fatigue) in which the mice
were placed for 24 h in a cage ﬁlled with water to a height of 1 cm.
Themouse spleens were harvested immediately after stress loading
and preserved at 80 C until analysis.
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Total RNA was extracted from spleen samples using the Bio-
Robot EZ1 workstation and EZ1 RNA Universal Tissue Kit (QIAGEN,
Inc.). cDNA was synthesized from total RNA using the PrimeScript
RT reagent Kit (Takara Bio Inc.). Mouse spleen mRNA levels of in-
ﬂammatory cytokines (IL-1b and IL-6), CD14 and CD16, and b-actin
(ACTB; internal control) were determined by real-time PCR with
the Applied Biosystems 7300 real-time PCR System (Applied Bio-
systems). Ampliﬁcations were performed in duplicate in a total
volume of 25 ml containing 12.5 ml of FastStart TaqMan Probe
Master (ROX) (Roche Diagnostics, Indianapolis, IN, USA), 0.225 ml of
PCR forward primer (100 mM), 0.225 ml of PCR reverse primer
(100 mM), 0.625 ml of TaqMan probe (10 mM), 2 ml of the cDNA, and
9.425 ml of PCR-grade water. The primers used for real-time PCR
were as follows: IL-1b forward primer, 50-CCTGAACTCAACTGT-
GAAATGCC- 3’; IL-1b reverse primer, 50-CTGCTGCGA-
GATTTGAAGCTG- 3’; IL-1b probe, 50-FAM-
TGCTCTCATCAGGACAGCCCAGGTCA-TAMRA-30; IL-6 forward
primer, 50-CCGGAGAGGAGACTTCACAGA- 3’; IL-6 reverse primer, 50-
GTTGTTCATACAATCAGAATTGCCATT- 3’; IL-6 probe, 50-FAM-
ACCACTCCCAACAGACCTGTCTATACCACT-TAMRA-30; CD14 forward
primer, 50-GCACACTCGCTCAACTTTTCC- 3’; CD14 reverse primer, 50-
CTTGGAGGGTCGGGAACTTG- 3’; CD14 probe, 50-FAM-
TCTTCCCTGCCCTCTCCACCTTAGACCT-TAMRA-30; CD16 forward
primer, 50-CAGTCCAAGCCTGTCACCATC- 3’; CD16 reverse primer,
50-GCACATCACTAGGGAGAAAGCA- 3; CD16 probe, 50-FAM-
TGTCCAAGACCCAGCAACTACATCCTCC-TAMRA-30; b-actin forward
primer, 50-CGCGAGCACAGCTTCTTTG- 3’; b-actin reverse primer: 50-
CGACCAGCGCAGCGATATC- 3’; and b-actin probe, 50-FAM-
CACACCCGCCACCAGTTCGCCATG-TAMRA-30. The thermal proﬁle
was 95 C for 10 min, followed by 45 cycles of 95 C for 10s and
60 C for 31s. Data analysis used Sequence Detection Software
version 1.4 (Applied Biosystems).
2.6. Flow cytometric analysis
Mouse spleens were placed into a 60 mm Petri dish and mashed
using the plunger end of a syringe. The cell suspension was sub-
jected to erythrocyte lysis using red blood cell lysis solution (Mil-
tenyi Biotech), and the cell pellet resuspended in RPMI 1640
medium supplemented with 10% FBS. Flow cytometric analysis was
performed on 1 106 spleen cells in 100 ml PBS supplemented with
0.5% BSA and 2 mM EDTA. FITC-conjugated rat anti-mouse CD14Fig. 1. VAS scores for feeling of fatigue (A), Numbers of HHV-6 (B) and HHV-7 (C) DNA copie
and error bars indicate s.e.m. Signiﬁcant differences between groups are indicated as *P <[clone rmC5-3] (BD Pharmingen) or FITC Rat IgG1, k isotype control
[clone 275003] (BD Pharmingen) was added and incubation con-
ducted for 10 min at 4 C in the dark, followed by addition of
allophycocyanin (APC)-conjugated rat anti-mouse Fc gamma RIII/
CD16 [clone 275003] (R&D Systems) or APC Rat IgG2A isotype
control [clone 54447] (R&D Systems) and further incubation for
30 min at 4 C in the dark. Next, cells were washed twice with PBS
supplemented with 0.5% BSA and 2 mM EDTA, and ﬁxed with 0.5%
paraformaldehyde. Flow cytometric analysis was performed on a
MACSQuant Analyzer using MACSQuantify software (Miltenyi
Biotech). Results were veriﬁed by performing at least ﬁve inde-
pendent experiments.
2.7. Statistical analysis
Data from the JSDF subjects were analyzed using repeated
measures analysis of variance (ANOVA). To compare two different
groups, Welch’s t-test was used. Multigroup comparisons were
performed using the Kruskal-Wallis test with Dunn’s multiple
comparisons test. Correlations between HHV-6 DNA quantities or
HHV-7 DNA quantities and clinical data were examined using
Spearman’s rank correlation coefﬁcients. P < 0.05 was considered
statistically signiﬁcant. Statistical analyses were conducted using
SPSS Statistics 21 for Windows (IBM Corporation) and Prism 6 for
Mac OS X (GraphPad Software, Inc.).
3. Results
3.1. Salivary HHV-6 and HHV-7 DNA copy numbers in JSDF
Feeling of fatigue steadily increased in the base training and
ﬁeld training and decreased with rest. However, after resting, it was
greater than before training (Fig. 1A). Salivary HHV-6 DNA
increased in the ﬁeld training and with rest decreased to the same
level as before training. (Fig. 1B). The Salivary HHV-7 DNA amount
increased in the base training and ﬁeld training and decreased with
rest, but after rest it was greater than before training, similar to
feeling of fatigue (Fig. 1C).
3.2. Changes in inﬂammatory cytokines and myeloid cell
differentiation markers in animal model of fatigue
Fatigue loading increased mRNA expression of interleukin 1b
(IL-1b) in mouse spleens (Fig. 2A), but there was no signiﬁcants are plotted at four points in the ranger training period. Horizontal lines show means
0.05, **P < 0.01, and ****P < 0.0001 using repeated measures ANOVA.
Fig. 2. Changes in inﬂammatory cytokines, myeloid cell differentiation markers in mouse spleens with fatigue loading. Spleen mRNA levels of IL-1b (A), IL-6 (B), CD14 (C) and CD16
(D) with fatigue (Fatigue; n ¼ 6) vs. no fatigue (Control; n ¼ 7). CD14 and CD16 positive monocyte levels with fatigue (Fatigue; n ¼ 7) vs. no fatigue (Control; n ¼ 6) (E). Positive rates
for CD14 and CD16 together vs. control (F). Horizontal lines indicate means and error bars s.e.m. Signiﬁcant differences between groups are indicated as *P < 0.05, n.s.: not sig-
niﬁcant by Welch’s t-test.
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and CD16 mRNA expressions (Fig. 2C and D) and FACS analysis
revealed an increase in CD14 and CD16 positive cells (mature
macrophages) (Fig. 2E and F) [16,17].
Salivary HHV-6 and HHV-7 DNA copy numbers in NC, OSAS, CFS
and depression.
As compared to the NCs, no signiﬁcant change in salivary HHV-6
DNA copy numbers was observed in the groups with, OSAS, CFS and
depression (Fig. 3A). Copy numbers of HHV-7 DNA were lower in
OSAS and CFS than in NCs (Fig. 3B).Fig. 3. HHV-6 (A) and HHV-7 (B) DNA copy numbers are plotted for NC, OSAS, CFS and
MDD. Horizontal lines indicate median values. **P < 0.01, n.s.: not signiﬁcant using
Kruskal-Wallis test with Dunn’s multiple comparisons.3.3. Correlations between HHV-6 and HHV-7 DNA copy numbers
and clinical assessments
HHV-6 and HHV-7 DNA copy numbers were weakly correlated
with working time per week in the NC group, excluding 3 subjects
whose working times were unknown (r ¼ 0.289, P ¼ 0.002**,
r¼ 0.240, P¼ 0.011*, n¼ 110, *P < 0.05, **P < 0.01, Spearman’s rank
correlation coefﬁcients) (Fig. 4A and B). No signiﬁcant correlations
were observed between HHV-6 and HHV-7 DNA copy numbers and
R. Aoki et al. / Biochemical and Biophysical Research Communications 478 (2016) 424e430428apnea-hypopnea index (AHI), Chalder Fatigue Scale or MADRS in
the NC, OSAS, CFS or MDD groups (Fig. 4CeH).
4. Discussion
We examined salivary HHV-6 and HHV-7 amounts due to
training in JSDF personnel. Since VAS fatigue scores increased
during training, we considered it provided sufﬁcient physiological
fatigue loading (Fig. 1A). Salivary HHV-6 and HHV-7 DNA amounts
increased with training and decreased with rest (Fig. 1 B and C),
suggesting usefulness as biomarkers of physiological fatigue. HHV-
6 DNA amounts quickly returned to the original levels with rest
suggesting that changes in HHV-7 DNA levels were more closely
matched to those in subjective fatigue.
To explore a mechanism for virus reactivation, we examined
fatigue-induced changes in mouse spleens, in whose abundant
macrophages latent virus infection is established [13]. There was anFig. 4. Correlations between HHV-6 and HHV-7 and working time per week in NCs (A and B
and H). n.s.: not signiﬁcant by Spearman’s rank correlation coefﬁcients.increase in IL-1b but not IL-6, and CD14 and CD16 expressions
increased in myeloid cells. Also, it was reported that physiological
fatigue, such as from exercise, induces inﬂammatory cytokines in
humans [30]. Inﬂammatory cytokines are involved in HHV-6
reactivation [14], myeloid cell differentiation is important in cyto-
megalovirus reactivation [31] and cytomegalovirus is similar to
HHV-6 and HHV-7 in nature. This suggests that a fatigue-induced
increase in IL-1b leads to macrophage activation and differentia-
tion, which in turn causes reactivation of HHV-6 and HHV-7.
To determinewhether salivary HHV-6 and HHV-7 DNA amounts
could also be biomarkers for pathological fatigue, we measured
them in OSAS, CFS and MDD. There were no increases as compared
with NCs (Fig. 3A and B). In OSAS and CFS, the HHV-7 DNA amount
was actually less than in NCs (Fig. 3B), probably due to reduced
physical activity. Disease severity was not correlated with HHV-6
and HHV-7 DNA amounts (Fig. 3 CeH).
However, in NCs, HHV-6 and HHV-7 DNA amounts were), AHI in OSAS (C and D), Chalder Fatigue Scale in CFS (E and F) and MADRS in MDD (G
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6 and HHV-7 are reactivated by physiological fatigue but not
pathological fatigue.
In OSAS, an increase in IL-6 was reported, but no increase in IL-
1b [32]. Various studies have examined associations between in-
ﬂammatory cytokines and CFS [33]. In severe CFS, there was no
increase in IL-1b or IL-6 [34]. For MDD, similar to OSAS, IL-6
increased but not IL-1b [35]. The lack of an increase in IL-1b with
pathological fatigue was considered a reason that it did not reac-
tivate the viruses.
Thus, salivary HHV-6 and HHV-7 were thought to be sensitive
biomarkers for physiological fatigue since they were not reac-
tivated by pathological fatigue. By distinguishing between the 2
types, they could assist in the diagnosis of patients with fatigue and
deciding on their treatment. Furthermore, HHV-6 and HHV-7
assessment would be more useful in preventing overwork than
methods relying on subjective feeling of fatigue, which can be
masked by motivation and incentives [7]. Also, saliva samples are
easy to collect and quantify for HHV-6 and HHV-7 in the primary
care setting.
Our ﬁndings should be helpful in the objective evaluation of
fatigue and answering remaining questions in fatigue science.
As a limitation, for comparisons between NC and OSAS, CFS and
MDD, subjects were not matched regarding age and gender due to
gender differences in disease prevalence and variation in ages of
susceptibility. However, as patterns of salivary HHV-6 and HHV-7
were similar in OSAS, CFS and MDD, the inﬂuence of this was
probably small.
Salivary HHV-6 and HHV-7 were shown to be useful objective
biomarkers for physiological fatigue. As they were not reactivated
by pathological fatigue, they could distinguish the 2 types of
fatigue.
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